Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics cash
Cash and short-term investments held at the end of each period.
Filana Therapeutics's cash was $82.68M at Jun 30, 2026. For fiscal 2025 it was $95.50M, down 25.7% from the year before. Over ten years it grew 11.8% a year on average. The highest annual figure on record is $233.44M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.50M | -25.7% |
| FY2024 | Dec 31, 2024 | $128.57M | +6.1% |
| FY2023 | Dec 31, 2023 | $121.14M | -39.7% |
| FY2022 | Dec 31, 2022 | $201.02M | -13.9% |
| FY2021 | Dec 31, 2021 | $233.44M | +149.6% |
| FY2020 | Dec 31, 2020 | $93.51M | +305.1% |
| FY2019 | Dec 31, 2019 | $23.08M | +16.5% |
| FY2018 | Dec 31, 2018 | $19.81M | +89.0% |
| FY2017 | Dec 31, 2017 | $10.48M | -44.0% |
| FY2016 | Dec 31, 2016 | $18.71M | -40.2% |
| FY2015 | Dec 31, 2015 | $31.30M | -22.9% |
| FY2014 | Dec 31, 2014 | $40.58M | -18.6% |
| FY2013 | Dec 31, 2013 | $49.84M | -11.4% |
| FY2012 | Dec 31, 2012 | $56.25M | -42.4% |
| FY2011 | Dec 31, 2011 | $97.73M | +7.1% |
| FY2010 | Dec 31, 2010 | $91.23M | +154.9% |
| FY2009 | Dec 31, 2009 | $35.79M | -76.6% |
| FY2008 | Dec 31, 2008 | $153.16M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $82.68M | -26.4% |
| Q1 FY2026 | Mar 31, 2026 | $86.57M | -26.2% |
| Q4 FY2025 | Dec 31, 2025 | $95.50M | -25.7% |
| Q3 FY2025 | Sep 30, 2025 | $106.08M | -28.8% |
| Q2 FY2025 | Jun 30, 2025 | $112.38M | -45.8% |
| Q1 FY2025 | Mar 31, 2025 | $117.33M | -5.5% |
| Q4 FY2024 | Dec 31, 2024 | $128.57M | +6.1% |
| Q3 FY2024 | Sep 30, 2024 | $148.98M | +4.7% |
| Q2 FY2024 | Jun 30, 2024 | $207.29M | +23.1% |
| Q1 FY2024 | Mar 31, 2024 | $124.17M | -33.8% |
| Q4 FY2023 | Dec 31, 2023 | $121.14M | -39.7% |
| Q3 FY2023 | Sep 30, 2023 | $142.35M | -18.5% |
| Q2 FY2023 | Jun 30, 2023 | $168.44M | -14.6% |
| Q1 FY2023 | Mar 31, 2023 | $187.47M | -10.6% |
| Q4 FY2022 | Dec 31, 2022 | $201.02M | -13.9% |
| Q3 FY2022 | Sep 30, 2022 | $174.66M | -27.7% |
| Q2 FY2022 | Jun 30, 2022 | $197.23M | -29.1% |
| Q1 FY2022 | Mar 31, 2022 | $209.69M | -25.7% |
| Q4 FY2021 | Dec 31, 2021 | $233.44M | +149.6% |
| Q3 FY2021 | Sep 30, 2021 | $241.52M | +903.3% |
| Q2 FY2021 | Jun 30, 2021 | $278.25M | +1001.8% |
| Q1 FY2021 | Mar 31, 2021 | $282.19M | +1002.3% |
| Q4 FY2020 | Dec 31, 2020 | $93.51M | +305.1% |
| Q3 FY2020 | Sep 30, 2020 | $24.07M | +35.2% |
| Q2 FY2020 | Jun 30, 2020 | $25.25M | +36.3% |
| Q1 FY2020 | Mar 31, 2020 | $25.60M | +33.9% |
| Q4 FY2019 | Dec 31, 2019 | $23.08M | +16.5% |
| Q3 FY2019 | Sep 30, 2019 | $17.80M | -12.9% |
| Q2 FY2019 | Jun 30, 2019 | $18.53M | +92.9% |
| Q1 FY2019 | Mar 31, 2019 | $19.13M | +78.2% |
| Q4 FY2018 | Dec 31, 2018 | $19.81M | +89.0% |
| Q3 FY2018 | Sep 30, 2018 | $20.44M | +71.6% |
| Q2 FY2018 | Jun 30, 2018 | $9.61M | -31.7% |
| Q1 FY2018 | Mar 31, 2018 | $10.73M | -37.8% |
| Q4 FY2017 | Dec 31, 2017 | $10.48M | -44.0% |
| Q3 FY2017 | Sep 30, 2017 | $11.92M | -45.2% |
| Q2 FY2017 | Jun 30, 2017 | $14.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.26M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.71M | – |
| Q3 FY2016 | Sep 30, 2016 | $21.76M | – |
See a number that looks wrong?